跳至主要内容
临床试验/NCT06393257
NCT06393257招募中不适用

Efficacy and Safety of Airway Clearance Technique by Oscillation and Lung Expansion in Patients With Bronchiectasis

Shanghai Pulmonary Hospital, Shanghai, China3 个研究点 分布在 1 个国家目标入组 96 人开始时间: 2023年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
96
试验地点
3
主要终点
sputum volume in 24h

研究概览

简要总结

The goal of this prospective randomized controlled trial is to explore the efficacy and safety of Oscillation and Lung Expansion-a airway clearance technology-in bronchiectasis. Participants will receive Oscillation and Lung Expansion or postural drainage randomly in this study. and the symptom, quality of life scores and amount of expectoration will be compared between the two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with acute exacerbation of bronchiectasis

排除标准

  • Haemoptysis greater than 50ml
  • state of endangerment
  • pneumothorax
  • Lung surgery history within 6 months
  • Severe heart, brain and nervous system diseases

研究组 & 干预措施

Oscillation and Lung Expansion

Experimental

干预措施: Oscillation and Lung Expansion (Device)

Oscillation and Lung Expansion

Experimental

干预措施: Anti-infective therapy (Drug)

Oscillation and Lung Expansion

Experimental

干预措施: Mucolytic (Drug)

postural drainage

Active Comparator

干预措施: Postural drainage (Behavioral)

postural drainage

Active Comparator

干预措施: Anti-infective therapy (Drug)

postural drainage

Active Comparator

干预措施: Mucolytic (Drug)

结局指标

主要结局

sputum volume in 24h

时间窗: 2 weeks

次要结局

  • Bronchiectasis exacerbation and symptom tool(Assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks post-discharge)
  • Quality of life questionnaire-bronchiectasis(Assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks post-discharge)
  • Leicester Cough Questionnaire(Assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks post-discharge)
  • Bronchiectasis Health Questionnaire(Assessed at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks post-discharge)
  • Time to the first bronchiectasis exacerbation since randomization(Assessed at 4 weeks, 8 weeks and 12 weeks post-discharge)

研究者

发起方
Shanghai Pulmonary Hospital, Shanghai, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jin-Fu Xu

Professor

Shanghai Pulmonary Hospital, Shanghai, China

研究点 (3)

Loading locations...

相似试验